Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Zakowska, D." wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł:
Protective antigen domain 4 of Bacillus anthracis as a candidate for use as vaccine for anthrax
Autorzy:
Żakowska, D.
Graniak, G.
Rutyna, P.
Naylor, K.
Glowacka, P.
Niemcewicz, M.
Powiązania:
https://bibliotekanauki.pl/articles/2085049.pdf
Data publikacji:
2019
Wydawca:
Instytut Medycyny Wsi
Tematy:
Bacillus anthracis
cloning pag gene
domain 4
protective antigen
protein
recombinant
vaccine
Opis:
Existing research for using the protective antigen (PA) of Bacillus anthracis as a vaccine component shows that protection against anthrax may be obtained using fragments of this protein. The aim of the research is to check whether the selected protein fragment of the protective antigen (domain 4) encoded by an appropriate nucleotide sequence of gene pag of B. anthracis, was expressed in the bacterial system of E. coli. In order to examine the selected sequence of the pag gene, a PCR reaction and a highly effective TOPO cloning strategy were used, followed by purification of the recombinant proteins and their detection by a western-blot method. In the planning of the PA4 antigen expression a higher level of effectiveness in production of small protein – domain 4 – was anticipated. As a result, the 139 amino acids protein fragment of B. anthracis PA (domain 4) was isolated. The research may have found the basis for in vivo research aimed at finding potential anthrax vaccine components.
Źródło:
Annals of Agricultural and Environmental Medicine; 2019, 26, 3; 392-395
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Microbiological analysis of bioaerosols collected from Hospital Emergency Departments and ambulances
Autorzy:
Bielawska-Drózd, A.
Cieślik, P.
Bohacz, J.
Kornillowicz-Kowalska, T.
Żakowska, D.
Bartoszcze, M.
Wlizło-Skowronek, B.
Winnicka, I.
Brytan, M.
Kubiak, L.
Skopińska-Różewska, E.
Kocik, J.
Powiązania:
https://bibliotekanauki.pl/articles/2081735.pdf
Data publikacji:
2018
Wydawca:
Instytut Medycyny Wsi
Tematy:
Button Sampler
bioaerosol
Hospital Emergency Departments
ambulances
bacteria
fungi
Opis:
Introduction and objective. The goal of the study was a microbiological, qualitative and quantitative analysis of bioaerosol at the workplace of medical personnel (Health Emergency Departments (HEDs), ambulances), and comparative administration offices with an expected neutral occupational exposure to biological agents measured with individual Button Sampler. Materials and method. Personal sampling was performed with Button Sampler instrument loaded with gelatine filters in 10 HEDs, in 9 ambulances and in 9 offices to assess the occupational biological agents’ exposure in air. Sampling was conducted from March until April 2016. Samples were quantitatively assessed for viable and total number of bacteria and fungi. Routine procedures for microbiological diagnostics were implemented. Data were analysed using Kruskal–Wallis and Mann-Whitney statistical tests with α=0.05. P value less than 0.05 were considered significant. Results. At the workplaces assessed, the concentrations of viable microorganisms in HEDs were 1.3 × 102 – 4.2 × 103 CFU/m3 for bacteria, 3.4 × 100 – 8.1 × 101 CFU/m3 for fungi; in ambulances 1.3 × 102 – 1.4 × 103 CFU/m3 (bacteria), 6.7 × 100 – 6.5 × 102 CFU/m3 (fungi) and in offices 4.2 × 101 – 5.0 × 103 CFU/m3 (bacteria), 0 – 7.9 × 102 CFU/m3 (fungi). In outdoor air, the number of microorganisms reached the level: 1.0 × 102 – 5.9 × 102 CFU/m3 for bacteria and 1.5 × 102 – 8.2 × 102 CFU/m3 for fungi. The predominant isolated bacteria were Gram-positive cocci. The prevalent fungi species belonged to the genus Aspergillus and Penicillium. Conclusions. The quantitative assessment of examined indoor air was similar to control outdoor air, and were relatively low. The level of microbiological contamination did not exceed 5 × 103 CFU/m3 which is recommended as an admissible level in public spaces in Poland.
Źródło:
Annals of Agricultural and Environmental Medicine; 2018, 25, 2; 274-279
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Utilization of Cereal and Milling Industry Products as Raw Materials for the Manufacture of Biopolymer Technical Products
Zagospodarowanie surowców przemysłu mączno-zbożowego do wytwarzania biopolimerowych produktów technicznych
Autorzy:
Ciechańska, D.
Kaszuba, L.
Żakowska, H.
Sulak, K.
Mik, T.
Janiga, M.
Wietecha, J.
Gutowska, A.
Kapuśniak, K.
Powiązania:
https://bibliotekanauki.pl/articles/949428.pdf
Data publikacji:
2016
Wydawca:
Sieć Badawcza Łukasiewicz - Instytut Biopolimerów i Włókien Chemicznych
Tematy:
cereal milling industry
functional biopolymers
bio-packaging materials
bio-thermoplastics
bio-adhesives
przemysł młynarski
biopolimery funkcyjne
produkty biopolimerowe
bio-kleje
Opis:
The pressure which is being exerted on manufacturers by the users of consumer goods towards more environmentally friendly applications, favours the use of already existing environmentally friendly raw materials or the search for new ones. One of the promising directions for research is aimed at developing new packaging materials based on biopolymers. Research recently conducted made it possible to use hydrothermally pre-treated starch/protein raw material in the manufacture of a new generation of biopolymer materials. Biopolymer products obtained by various modifications were used to produce an exemplary batches of mouldings and packaging materials (films, corrugated cardboard).
Nacisk wywierany przez użytkowników dóbr konsumpcyjnych, ukierunkowany na zastosowanie bardziej proekologiczne, powoduje stosowanie już istniejących lub poszukiwanie nowych surowców i materiałów przyjaznych środowisku. Jednym z kierunków rokujących duże nadzieje są badania mające na celu opracowanie nowych materiałów opakowaniowych do wytworzenia, których wykorzystywane będą surowce biopolimerowe. Wykonane prace badawcze pozwoliły na wykorzystanie wstępnie zmodyfikowanego hydrotermicznie surowca skrobiowo-białkowego do wytworzenia nowej generacji materiałów biopolimerowych. Uzyskane w wyniku modyfikacji produkty posłużyły, z kolei, do wytworzenia demonstracyjnych partii materiałów biopolimerowe - folii, kształtek oraz klejów do tektur wielowarstwowych.
Źródło:
Fibres & Textiles in Eastern Europe; 2016, 6 (120); 175-180
1230-3666
2300-7354
Pojawia się w:
Fibres & Textiles in Eastern Europe
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Bacillus anthracis infections – new possibilities of treatment
Autorzy:
Zakowska, D.
Bartoszcze, M.
Niemcewicz, M.
Bielawska-Drozd, A.
Knap, J.
Cieslik, P.
Chomiczewski, K.
Kocik, J.
Powiązania:
https://bibliotekanauki.pl/articles/51666.pdf
Data publikacji:
2015
Wydawca:
Instytut Medycyny Wsi
Źródło:
Annals of Agricultural and Environmental Medicine; 2015, 22, 2
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Q fever - selected issues
Autorzy:
Bielawska-Drozd, A.
Cieslik, P.
Mirski, T.
Bartoszcze, M.
Knap, J.P.
Gawel, J.
Zakowska, D.
Powiązania:
https://bibliotekanauki.pl/articles/49820.pdf
Data publikacji:
2013
Wydawca:
Instytut Medycyny Wsi
Tematy:
Q fever
animal species
man
Coxiella burnetii
intracellular parasite
parasite
htpAB gene
IS1111 gene
genome
plasmid
pathomechanism
infection
bioterrorism
epidemiology
epizootiology
treatment
prophylaxis
laboratory diagnostics
serological method
molecular diagnostics
Opis:
Q fever is an infectious disease of humans and animals caused by Gram-negative coccobacillus Coxiella burnetii, belonging to the Legionellales order, Coxiellaceae family. The presented study compares selected features of the bacteria genome, including chromosome and plasmids QpH1, QpRS, QpDG and QpDV. The pathomechanism of infection – starting from internalization of the bacteria to its release from infected cell are thoroughly described. The drugs of choice for the treatment of acute Q fever are tetracyclines, macrolides and quinolones. Some other antimicrobials are also active against C. burnetii, namely, telitromycines and tigecyclines (glicylcycline). Q-VAX vaccine induces strong and long-term immunity in humans. Coxevac vaccine for goat and sheep can reduce the number of infections and abortions, as well as decrease the environmental transmission of the pathogen. Using the microarrays technique, about 50 proteins has been identified which could be used in the future for the production of vaccine against Q fever. The routine method of C. burnetii culture is proliferation within cell lines; however, an artificial culture medium has recently been developed. The growth of bacteria in a reduced oxygen (2.5%) atmosphere was obtained after just 6 days. In serology, using the IF method as positive titers, the IgM antibody level >1:64 and IgG antibody level >1:256 (against II phase antigens) has been considered. In molecular diagnostics of C. burnetii infection, the most frequently used method is PCR and its modifications; namely, nested PCR and real time PCR which detect target sequences, such as htpAB and IS1111, chromosome genes (com1), genes specific for different types of plasmids and transposase genes. Although Q fever was diagnosed in Poland in 1956, the data about the occurrence of the disease are incomplete. Comprehensive studies on the current status of Q fever in Poland, with special focus on pathogen reservoirs and vectors, the sources of infection and molecular characteristics of bacteria should be conducted.
Źródło:
Annals of Agricultural and Environmental Medicine; 2013, 20, 2
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies